A Study of LY3209590 on Low Blood Sugar in Participants With Type 2 Diabetes Mellitus

Clinical trial NCT04957914 · COMPLETED

Trial details

NCT number: NCT04957914
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2021-07-14
Primary completion: 2022-10-17
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.